Michael P Vincent
Overview
Explore the profile of Michael P Vincent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oswald B, DeCamp L, Longo J, Dahabieh M, Bunda N, Ma S, et al.
bioRxiv
. 2024 Nov;
PMID: 39605550
Reducing calorie intake without malnutrition limits tumor progression but the underlying mechanisms are poorly understood. Here we show that dietary restriction (DR) suppresses tumor growth by enhancing CD8 T cell-mediated...
2.
Longo J, DeCamp L, Oswald B, Teis R, Reyes-Oliveras A, Dahabieh M, et al.
bioRxiv
. 2024 Oct;
PMID: 39464161
Glucose is essential for T cell proliferation and function, yet its specific metabolic roles remain poorly defined. Here, we identify glycosphingolipid (GSL) biosynthesis as a key pathway fueled by glucose...
3.
House R, Soper-Hopper M, Vincent M, Ellis A, Capan C, Madaj Z, et al.
Nat Commun
. 2024 Jul;
15(1):5796.
PMID: 38987243
Metabolite extraction is the critical first-step in metabolomics experiments, where it is generally regarded to inactivate and remove proteins. Here, arising from efforts to improve extraction conditions for polar metabolomics,...
4.
Du F, Yuk S, Qian Y, Vincent M, Bobbala S, Abbott T, et al.
Res Sq
. 2024 May;
PMID: 38746232
The development of subunit vaccines that mimic the molecular complexity of attenuated vaccines has been limited by the difficulty of intracellular co-delivery of multiple chemically diverse payloads at controllable concentrations....
5.
Carrow K, Hamilton H, Hopps M, Li Y, Qiao B, Payne N, et al.
Adv Mater
. 2024 Jan;
36(21):e2311467.
PMID: 38241649
Successful and selective inhibition of the cytosolic protein-protein interaction (PPI) between nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associating protein 1 (Keap1) can enhance the antioxidant response, with...
6.
Du F, Rische C, Li Y, Vincent M, Krier-Burris R, Qian Y, et al.
Nat Nanotechnol
. 2024 Jan;
19(5):698-704.
PMID: 38228804
Protein adsorption onto nanomaterials often results in denaturation and loss of bioactivity. Controlling the adsorption process to maintain the protein structure and function has potential for a range of applications....
7.
Gingerich M, Zhu J, Chai B, Vincent M, Xie N, Sidarala V, et al.
J Biol Chem
. 2023 Feb;
299(4):103057.
PMID: 36822331
CLEC16A is an E3 ubiquitin ligase that regulates mitochondrial quality control through mitophagy and is associated with over 20 human diseases. CLEC16A forms a complex with another E3 ligase, RNF41,...
8.
Du F, Rische C, Li Y, Vincent M, Krier-Burris R, Qian Y, et al.
Res Sq
. 2023 Feb;
PMID: 36747749
No abstract available.
9.
Yi S, Kim S, Vincent M, Yuk S, Bobbala S, Du F, et al.
iScience
. 2022 Jun;
25(7):104555.
PMID: 35769884
Plasmid DNA (pDNA) transfection is advantageous for gene therapies requiring larger genetic elements, including "all-in-one" CRISPR/Cas9 plasmids, but is limited by toxicity as well as poor intracellular release and transfection...
10.
Gingerich M, Liu X, Chai B, Pearson G, Vincent M, Stromer T, et al.
Autophagy
. 2022 May;
19(2):525-543.
PMID: 35604110
CLEC16A regulates mitochondrial health through mitophagy and is associated with over 20 human diseases. However, the key structural and functional regions of CLEC16A, and their relevance for human disease, remain...